KR102047030B1 - 바이러스 벡터 제조 - Google Patents

바이러스 벡터 제조 Download PDF

Info

Publication number
KR102047030B1
KR102047030B1 KR1020167014693A KR20167014693A KR102047030B1 KR 102047030 B1 KR102047030 B1 KR 102047030B1 KR 1020167014693 A KR1020167014693 A KR 1020167014693A KR 20167014693 A KR20167014693 A KR 20167014693A KR 102047030 B1 KR102047030 B1 KR 102047030B1
Authority
KR
South Korea
Prior art keywords
cell
virus
cells
cho
sequence
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
KR1020167014693A
Other languages
English (en)
Korean (ko)
Other versions
KR20160079868A (ko
Inventor
폴 마이클 하울리
리앙 리우
Original Assignee
세멘티스 리미티드
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AU2013904242A external-priority patent/AU2013904242A0/en
Application filed by 세멘티스 리미티드 filed Critical 세멘티스 리미티드
Publication of KR20160079868A publication Critical patent/KR20160079868A/ko
Application granted granted Critical
Publication of KR102047030B1 publication Critical patent/KR102047030B1/ko
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24151—Methods of production or purification of viral material
    • C12N2710/24152—Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
KR1020167014693A 2013-11-01 2014-11-03 바이러스 벡터 제조 Active KR102047030B1 (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
AU2013904242 2013-11-01
AU2013904242A AU2013904242A0 (en) 2013-11-01 Viral vector manufacture
AU2014900370 2014-02-07
AU2014900370A AU2014900370A0 (en) 2014-02-07 Orthopox vectors and propagation
PCT/AU2014/050330 WO2015061858A1 (en) 2013-11-01 2014-11-03 Viral vector manufacture

Publications (2)

Publication Number Publication Date
KR20160079868A KR20160079868A (ko) 2016-07-06
KR102047030B1 true KR102047030B1 (ko) 2019-11-20

Family

ID=53003022

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020167014693A Active KR102047030B1 (ko) 2013-11-01 2014-11-03 바이러스 벡터 제조

Country Status (25)

Country Link
US (2) US10544397B2 (https=)
EP (2) EP3375882B1 (https=)
JP (2) JP6682443B2 (https=)
KR (1) KR102047030B1 (https=)
CN (1) CN106255758B (https=)
AU (1) AU2014344738B2 (https=)
CA (1) CA2931518C (https=)
CY (1) CY1121414T1 (https=)
DK (2) DK3063278T3 (https=)
ES (1) ES2670034T3 (https=)
HR (1) HRP20180789T1 (https=)
HU (1) HUE037718T2 (https=)
IL (1) IL245363B (https=)
LT (1) LT3063278T (https=)
NO (1) NO3063278T3 (https=)
NZ (1) NZ720241A (https=)
PL (1) PL3063278T3 (https=)
PT (1) PT3063278T (https=)
RS (1) RS57290B1 (https=)
RU (1) RU2658487C2 (https=)
SG (1) SG11201603919XA (https=)
SI (1) SI3063278T1 (https=)
SM (1) SMT201800267T1 (https=)
TR (1) TR201807128T4 (https=)
WO (1) WO2015061858A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL264893B (en) * 2016-08-19 2022-08-01 Sementis Ltd Vaccines for viruses
JP2018081568A (ja) * 2016-11-17 2018-05-24 グローリー株式会社 紙幣収納装置および紙幣処理機
IL295154A (en) * 2020-01-28 2022-09-01 Lonza Walkersville Inc Methods for determining viral titer
EP4547689A1 (en) * 2022-06-30 2025-05-07 Bavarian Nordic A/S Mammalian cell line for the production of modified vaccinia virus ankara (mva)
WO2024064608A2 (en) * 2022-09-20 2024-03-28 Intergalactic Therapeutics, Inc. Best1 vectors and uses thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2604183B1 (fr) 1986-09-23 1988-12-30 Transgene Sa Sequence d'adn, vecteurs, virus recombinants et procede mettant en oeuvre des virus de la vaccine recombinants capables de se multiplier dans les cellules cho
ATE298370T1 (de) 1994-04-29 2005-07-15 Baxter Healthcare Sa Rekombinante poxviren mit fremdenpolynukleotiden in wichtigen regionen
WO2004015118A1 (en) * 2002-08-07 2004-02-19 Bavarian Nordic A/S Vaccinia virus host range genes to increase the titer of avipoxviruses
FR2884255B1 (fr) * 2005-04-11 2010-11-05 Vivalis Utilisation de lignees de cellules souches aviaires ebx pour la production de vaccin contre la grippe
CA2658301A1 (en) * 2006-08-04 2008-02-07 Dublin City University A method of producing recombinant biological products

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
Ramsey-Ewing, AL. et al., Virology, (1996) 222:75-86*

Also Published As

Publication number Publication date
CN106255758A (zh) 2016-12-21
ES2670034T3 (es) 2018-05-29
WO2015061858A1 (en) 2015-05-07
AU2014344738B2 (en) 2019-03-21
CY1121414T1 (el) 2020-05-29
DK3063278T3 (en) 2018-06-06
EP3063278B1 (en) 2018-02-28
PT3063278T (pt) 2018-05-25
RU2016121425A (ru) 2017-12-04
JP6682443B2 (ja) 2020-04-15
US10544397B2 (en) 2020-01-28
IL245363B (en) 2020-01-30
DK3375882T3 (da) 2019-12-16
HUE037718T2 (hu) 2018-09-28
JP2020039340A (ja) 2020-03-19
IL245363A0 (en) 2016-06-30
EP3375882A1 (en) 2018-09-19
SG11201603919XA (en) 2016-07-28
PL3063278T3 (pl) 2018-08-31
AU2014344738A1 (en) 2016-06-09
US20170029784A1 (en) 2017-02-02
SMT201800267T1 (it) 2018-07-17
NO3063278T3 (https=) 2018-07-28
EP3375882B1 (en) 2019-10-16
NZ720241A (en) 2019-10-25
KR20160079868A (ko) 2016-07-06
HRP20180789T1 (hr) 2018-09-07
RU2658487C2 (ru) 2018-06-21
CA2931518C (en) 2021-03-09
EP3063278A4 (en) 2017-04-12
LT3063278T (lt) 2018-07-10
HK1223395A1 (en) 2017-07-28
SI3063278T1 (sl) 2019-04-30
JP2016534755A (ja) 2016-11-10
US20200190482A1 (en) 2020-06-18
RS57290B1 (sr) 2018-08-31
EP3063278A1 (en) 2016-09-07
CA2931518A1 (en) 2015-05-07
TR201807128T4 (tr) 2018-06-21
CN106255758B (zh) 2020-06-23

Similar Documents

Publication Publication Date Title
AU2019377141B2 (en) Enhanced systems for cell-mediated oncolytic viral therapy
CN110199018B (zh) 嵌合痘病毒组合物及其用途
AU2020229875B2 (en) Immunostimulatory bacteria engineered to colonize tumors, tumor-resident immune cells, and the tumor microenvironment
KR102357051B1 (ko) 신규 유전자 재조합 백시니아 바이러스
KR20220030205A (ko) 면역 세포의 트랜스포존 기반 변형
KR20170048396A (ko) 재조합 변형된 백시니아 바이러스 앙카라 (mva) 필로바이러스 백신
KR20010024296A (ko) 벡터 구조체와 세포 ｄｎａ의 비상동 재조합법에 의한내생 유전자 발현
KR102047030B1 (ko) 바이러스 벡터 제조
KR20230034933A (ko) Covid-19에 대한 보호를 위한 약독화된 폭스바이러스 벡터 기반 백신
CN112739359A (zh) Apmv及其用于治疗癌症的用途
EP4331676A2 (en) Viral vaccines
HK1260426A1 (en) Viral vector manufacture
HK1260426B (en) Viral vector manufacture
HK1223395B (en) Viral vector manufacture
CN117999090A (zh) 鼠痘病毒用于癌症免疫治疗和疫苗的用途
KR20200124713A (ko) 외인성 펠라인 파라믹소바이러스 유전자를 발현하는 재조합 바이러스 벡터 시스템 및 이로부터 제조된 백신

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20160601

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20180327

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20190411

Patent event code: PE09021S01D

E701 Decision to grant or registration of patent right
PE0701 Decision of registration

Patent event code: PE07011S01D

Comment text: Decision to Grant Registration

Patent event date: 20191028

GRNT Written decision to grant
PR0701 Registration of establishment

Comment text: Registration of Establishment

Patent event date: 20191114

Patent event code: PR07011E01D

PR1002 Payment of registration fee

Payment date: 20191115

End annual number: 3

Start annual number: 1

PG1601 Publication of registration
FPAY Annual fee payment

Payment date: 20220929

Year of fee payment: 4

PR1001 Payment of annual fee

Payment date: 20220929

Start annual number: 4

End annual number: 4

PR1001 Payment of annual fee

Payment date: 20231004

Start annual number: 5

End annual number: 5

PR1001 Payment of annual fee

Payment date: 20240927

Start annual number: 6

End annual number: 6